Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here
Saturday, November 24, 2012
Holy Name will screen 2,000 for Hepatitis B
About 2,000 Asians will be screened for the virus over the next year as part of an awareness campaign made possible by a $75,000 grant from the Gilead Foundation to the hospital's center. The center will provide vaccinations to those who have not been inoculated and are not carrying the virus. Carriers can be given antiviral medications to prevent serious damage from the virus. Hepatitis B is not curable.
Though experts don't know why, hepatitis B is four to 10 times more likely to be diagnosed in Asians than in whites in the United States, said Dr. Chul S. Hyun, a gastroenterologist and medical director of the Asian Liver Center at Holy Name Medical Center in Teaneck.